We also explored the impact of these biomarkers on overall survival in our population and found that longer overall survival was associated with the presence of MGMT promoter methylation (in grade III and IV) and 1p19q co-deletion (in grade III glioma only). The gene discussed is MGMT; the disease is glioma.